Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Envoy Medical Inc. (COCHW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: COCHW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -55% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 30440 | Beta 2.38 | 52 Weeks Range 0.03 - 0.24 | Updated Date 04/1/2025 |
52 Weeks Range 0.03 - 0.24 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -10771.43% |
Management Effectiveness
Return on Assets (TTM) -125.51% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10717479 |
Shares Outstanding - | Shares Floating 10717479 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc. is a hearing health company focused on innovative, fully implanted hearing solutions. The company was founded to address the limitations of traditional hearing aids and cochlear implants. While a private company for many years, Envoy Medical became a public company in 2023.
Core Business Areas
- Fully Implanted Hearing Aids: Envoy Medical focuses on developing and commercializing fully implanted hearing devices that bypass many of the limitations of traditional hearing aids. Their flagship product, the Esteem, is a prime example.
Leadership and Structure
Details about the specific leadership team and detailed organizational structure were not readily available publicly.
Top Products and Market Share
Key Offerings
- Esteem Fully Implanted Hearing Aid: The Esteem is a fully implanted hearing aid designed to restore natural hearing. It uses the body's own natural mechanics to amplify sound. Because it is fully implanted the product is hidden and requires no maintainence from the patient. Market share information is not readily available, as this is a niche market within the broader hearing aid industry. Competitors: Oticon Medical (cochlear implants), Cochlear Limited (cochlear implants), and Sonova (hearing aids, though not fully implanted).
Market Dynamics
Industry Overview
The hearing aid industry is characterized by an aging population, increasing awareness of hearing loss, and technological advancements. The fully implanted segment is a small, emerging niche within the larger hearing aid market.
Positioning
Envoy Medical is positioned as an innovator in the fully implanted hearing aid space, offering a unique product compared to traditional hearing aids and cochlear implants.
Total Addressable Market (TAM)
Estimates of the TAM for fully implanted hearing aids are difficult to obtain due to the niche nature of the market. However, the overall hearing aid market is substantial, with some sources estimating the global hearing aid market to reach nearly $10 billion in the coming years. Envoy Medical is positioned to capture a portion of this market with its unique fully implanted technology.
Upturn SWOT Analysis
Strengths
- Innovative fully implanted technology
- Potential for superior sound quality compared to traditional hearing aids
- Discreet and convenient design
- Eliminates the need for daily maintenance.
Weaknesses
- High cost
- Surgical implantation required
- Limited market awareness
- Reliance on a single core product
Opportunities
- Expanding market awareness through targeted marketing
- Developing next-generation fully implanted hearing solutions
- Partnering with audiologists and ENT specialists
- Geographic expansion
Threats
- Competition from established hearing aid manufacturers
- Technological advancements in traditional hearing aids
- Regulatory hurdles
- Economic downturn affecting consumer spending
Competitors and Market Share
Key Competitors
- COCH
- SONO
- OTCM
Competitive Landscape
Envoy Medical's advantage lies in its fully implanted technology, which offers unique benefits. However, it faces competition from established players with greater resources and broader product portfolios.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is not readily available.
Future Projections: Future growth projections are not readily available. However, the company's success depends on increasing market adoption of its fully implanted hearing aid technology.
Recent Initiatives: Recent initiatives include ongoing clinical trials and commercialization efforts for the Esteem.
Summary
Envoy Medical is a niche player in the hearing aid market with a unique, fully implanted product. While its technology is innovative, it faces challenges related to cost, surgical requirements, and market awareness. The company's future success hinges on successfully commercializing its Esteem device and expanding its market reach.
Similar Companies
COCH
Envoy Medical Inc.
COCH
Envoy Medical Inc.
SONO
Sonos Inc
SONO
Sonos Inc
Sources and Disclaimers
Data Sources:
- Company website
- Industry reports
- SEC filings
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share data may be estimated and subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-23 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 34 | Website https://www.envoymedical.com |
Full time employees 34 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.